Ad Scientiam a été sélectionné par un jury d’experts français et allemands composé de spécialistes du marché allemand ...

Ad Scientiam was selected by the Ile-de-France Regional Council for the PM’up program. Ad Scientiam's digital biomarker development project is fully aligned ...

The development of MSCopilot® has been selected to benefit from innovation aid under the Innov'up Leader PIA scheme, jointly funded by the State and the Ile-de-France Regional Council and operated by Bpifrance ...

Ad Scientiam’s solution, MSCopilot® (Digital self-Assessment for Multiple Sclerosis), was awarded the Seal of Excellence by the European Commission at the Horizon 2020 competition !

Ad Scientiam lauréat du Concours d’Innovation Numérique 2017 29 juin 2017 Nous sommes fiers  d’annoncer que bpifrance nous a distingué ...

Organized by the U.S. Department of Commerce and SelectUSA, this program has been designed for high-growth startups in the healthcare IT, healthcare services, and health tech industries with secured investments ...